Literature DB >> 30304506

Host and microbial factors in kidney transplant recipients with Escherichia coli acute pyelonephritis or asymptomatic bacteriuria: a prospective study using whole-genome sequencing.

Julien Coussement1,2, Maria Angeles Argudín1, Amélie Heinrichs1, Judith Racapé3,4, Ricardo de Mendonça1, Louise Nienhaus1, Alain Le Moine4, Sandrine Roisin1, Magali Dodémont1, Frédérique Jacobs2, Daniel Abramowicz5, Brian D Johnston6, James R Johnson6, Olivier Denis1,7.   

Abstract

BACKGROUND: Urinary tract infection is the most common infection among kidney transplant recipients (KTRs). Many transplant physicians fear that host compromise will allow low-virulence strains to cause pyelonephritis in KTRs, so they often treat asymptomatic bacteriuria with antibiotics. Identification of the host/microbe factors that determine the clinical presentation (i.e. pyelonephritis versus asymptomatic bacteriuria) once an Escherichia coli strain enters a KTRs bladder could inform management decisions.
METHODS: We prospectively collected all E. coli isolates causing either pyelonephritis or asymptomatic bacteriuria in KTRs at our institution (December 2012-June 2015). Whole-genome sequencing was used to assess bacterial characteristics (carriage of 48 virulence genes and phylogenetic and clonal background). Host parameters were also collected.
RESULTS: We analysed 72 bacteriuria episodes in 54 KTRs (53 pyelonephritis, 19 asymptomatic bacteriuria). The pyelonephritis and asymptomatic bacteriuria isolates exhibited a similar total virulence gene count per isolate [median 18 (range 5-33) and 18 (5-30), respectively; P = 0.57] and for individual virulence genes differed significantly only for the prevalence of the pap operon (pyelonephritis 39%,versus asymptomatic bacteriuria 0%; P = 0.002). No other significant between-group differences were apparent for 86 other bacterial and host variables.
CONCLUSIONS: Our findings suggest that bacterial adherence plays a role in the pathogenesis of pyelonephritis in KTRs despite significantly altered host urinary tract anatomy and weakened immunity. Whether KTRs might benefit from targeted therapies (e.g. vaccination or inhibitors of fimbrial adhesion) has yet to be studied.
© The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  ExPEC; NGS; UPEC; urinary tract infections; virulome

Mesh:

Substances:

Year:  2019        PMID: 30304506     DOI: 10.1093/ndt/gfy292

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages.

Authors:  Michael Biggel; Basil B Xavier; James R Johnson; Karen L Nielsen; Niels Frimodt-Møller; Veerle Matheeussen; Herman Goossens; Pieter Moons; Sandra Van Puyvelde
Journal:  Nat Commun       Date:  2020-11-24       Impact factor: 14.919

2.  Molecular epidemiology of blaCTX-M gene-producing uropathogenic Escherichia coli among Iranian kidney transplant patients: clonal dissemination of CC131 and CC10.

Authors:  Mehrdad Halaji; Shahrzad Shahidi; Behrooz Ataei; Abdolamir Atapour; Awat Feizi; Seyed Asghar Havaei
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-09-08       Impact factor: 3.944

Review 3.  Recurrent Urinary Tract Infections and Asymptomatic Bacteriuria in Adults.

Authors:  David Hernández-Hernández; Bárbara Padilla-Fernández; María Yanira Ortega-González; David Manuel Castro-Díaz
Journal:  Curr Bladder Dysfunct Rep       Date:  2021-12-01

4.  Characterization of Plasmid-Mediated Quinolone Resistance and Serogroup Distributions of Uropathogenic Escherichia coli among Iranian Kidney Transplant Patients.

Authors:  Amin Sadeghi; Mehrdad Halaji; Amirhossein Fayyazi; Seyed Asghar Havaei
Journal:  Biomed Res Int       Date:  2020-10-27       Impact factor: 3.411

Review 5.  Gut microbiota, key to unlocking the door of diabetic kidney disease.

Authors:  Peipei Wang; Ting Wang; Xuejun Zheng; Wen Cui; Jin Shang; Zhanzheng Zhao
Journal:  Nephrology (Carlton)       Date:  2021-03-18       Impact factor: 2.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.